Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription

Articles published in J Clin Virol

Retrieve available abstracts of 17 articles:
HTML format

Single Articles

    June 2024
  1. POLJAK M, Ostrbenk Valencak A, Cuschieri K, Bohinc KB, et al
    2023 global inventory of commercial molecular tests for human papillomaviruses (HPV).
    J Clin Virol. 2024;172:105671.
    PubMed     Abstract available

    April 2024
  2. PRETET JL, Arroyo Muhr LS, Cuschieri K, Fellner MD, et al
    Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
    J Clin Virol. 2024;171:105657.
    PubMed     Abstract available

  3. HEIDEMAN DAM, Berkhof J, Verhoef L, Ouwerkerk C, et al
    Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
    J Clin Virol. 2024;171:105649.
    PubMed     Abstract available

    February 2024
  4. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    Corrigendum to "First international proficiency study on human papillomavirus testing in cervical cancer screening" [J Clin Virol. 2023 Oct;167:105581].
    J Clin Virol. 2024;171:105660.

    January 2024
  5. OSTRBENK VALENCAK A, Cuschieri K, Connor L, Zore A, et al
    Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
    J Clin Virol. 2024;170:105638.
    PubMed     Abstract available

    September 2023
  6. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    First international proficiency study on human papillomavirus testing in cervical cancer screening.
    J Clin Virol. 2023;167:105581.
    PubMed     Abstract available

    July 2023
  7. ELASIFER H, Amukwaya MMN, Bhatia R, Cuschieri K, et al
    The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
    J Clin Virol. 2023;164:105469.
    PubMed     Abstract available

    March 2023
  8. MONTERO-MACIAS R, Veyer D, Bruneau T, Robillard N, et al
    TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion.
    J Clin Virol. 2023;161:105418.
    PubMed     Abstract available

    February 2023
  9. GARLAND SM, Iftner T, Cuschieri K, Kaufmann AM, et al
    IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.
    J Clin Virol. 2023;159:105349.
    PubMed     Abstract available

    October 2022
  10. VAN KEER S, Latsuzbaia A, Vanden Broeck D, De Sutter P, et al
    Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.
    J Clin Virol. 2022;155:105271.
    PubMed     Abstract available

    July 2022
  11. ARROYO MUHR LS, Eklund C, Lagheden C, Forslund O, et al
    Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study.
    J Clin Virol. 2022;154:105237.
    PubMed     Abstract available

    June 2022
  12. BHATIA R, Graham C, Elasifer H, Asodaria P, et al
    Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.
    J Clin Virol. 2022;150-151:105165.
    PubMed     Abstract available

    December 2021
  13. RAINE-BENNETT T, Gage JC, Poitras N, Chandra M, et al
    Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS).
    J Clin Virol. 2021;145:105014.
    PubMed     Abstract available

  14. JOSEPH J, Mangwendeza P, Maparo T, Mhizha T, et al
    Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe.
    J Clin Virol. 2021;145:105017.
    PubMed     Abstract available

    August 2021
  15. EKLUND C, Muhr LSA, Lagheden C, Forslund O, et al
    The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.
    J Clin Virol. 2021;141:104902.
    PubMed     Abstract available

    July 2021
  16. OSTRBENK VALENCAK A, Bertram A, Groning A, Poljak M, et al
    Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting.
    J Clin Virol. 2021;140:104851.
    PubMed     Abstract available

    April 2021
  17. CUSCHIERI K, Wilson A, Palmer T, Stanczuk G, et al
    The challenges of defining sample adequacy in an era of HPV based cervical screening.
    J Clin Virol. 2021;137:104756.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.